首页> 外国专利> Immortal unipotent porcine PICM-19H and PICM-19B stem cell lines

Immortal unipotent porcine PICM-19H and PICM-19B stem cell lines

机译:永生的单能猪PICM-19H和PICM-19B干细胞系

摘要

Two cell lines, PICM-19H and PICM-19B, were derived from the bipotent ARS-PICM-19 pig liver stem cell line. The unipotent porcine stem cell line PICM-19H differentiates exclusively into hepatocytes and can be induced to express CYP450 enzymes. The growth rate and cell density in culture, morphological features, and hepatocyte detoxification functions, i.e., inducible CYP450 activity, ammonia clearance, and urea production of the PICM-19H cells were evaluated for their application in artificial liver devices. PICM-19H cells contain numerous mitochondria, Golgi apparatus, smooth and rough endoplasmic reticulum, vesicular bodies and occasional lipid vacuoles and display inducible CYP450 activity, clear ammonia, and produce urea in a glutamine-free medium. The data indicate that both cell lines, either together or alone, may be useful as the cellular substrate for an artificial liver device. The results demonstrate the potential for the use of PICM-19H cells in drug biotransformation and toxicity testing.
机译:两种细胞系PICM-19H和PICM-19B均来自双能ARS-PICM-19猪肝干细胞系。单能猪干细胞系PICM-19H仅分化为肝细胞,可被诱导表达CYP450酶。评估了PICM-19H细胞在培养物中的生长速率和细胞密度,形态特征和肝细胞解毒功能,即可诱导的CYP450活性,氨清除率和尿素生成,以将其应用于人造肝设备。 PICM-19H细胞包含许多线粒体,高尔基体,光滑且粗糙的内质网,囊泡体和偶尔的脂质液泡,并显示可诱导的CYP450活性,清除氨并在无谷氨酰胺的培养基中产生尿素。数据表明,两种细胞系一起或单独都可用作人工肝装置的细胞底物。结果证明了在药物生物转化和毒性测试中使用PICM-19H细胞的潜力。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号